Article Details

Ropeginterferon Alfa-2b Demonstrates Long-Term QOL Improvements in Polycythemia Vera

Retrieved on: 2022-06-13 19:04:56

Tags for this article:

Click the tags to see associated articles and topics

Ropeginterferon Alfa-2b Demonstrates Long-Term QOL Improvements in Polycythemia Vera. View article details on HISWAI: https://www.onclive.com/view/ropeginterferon-alfa-2b-demonstrates-long-term-qol-improvements-in-polycythemia-vera

Excerpt

Treatment with ropeginterferon alfa-2b-njft induced low symptom burden and low phlebotomy requirement compared with best available treatment in ...

Article found on: www.onclive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up